Last updated on June 2018

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)


Brief description of study

This is multi-center, randomized, double-blind, parallel, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of FURESTEM-AD Inj. for moderate to severe chronic atopic dermatitis

Clinical Study Identifier: NCT03269773

Contact Investigators or Research Sites near you

Start Over

Tae-Yoon Kim, Professor

Catholic Medical Center
Seoul, Korea, Republic of
  Connect »

Moon-Bum Kim, Professor

Pusan National University Hospital
Busan, Korea, Republic of
  Connect »

Seung-Chul Lee, Professor

Chonnam National University Hospital
Gwangju, Korea, Republic of
  Connect »

Ai-Young Lee, Professor

Dongguk University Medical Center
Ilsan, Korea, Republic of
  Connect »

Joo-Young Roh, Professor

Gachon University Gil Medical Center
Incheon, Korea, Republic of
  Connect »

Chong-Hyun Won, Professor

Asan Medical Center
Seoul, Korea, Republic of
  Connect »

Seoung-Jun Seo, Professor

Chung-Ang University Healthcare System
Seoul, Korea, Republic of
  Connect »

Young-Suck Ro, Professor

Hanyang University Medical Center
Seoul, Korea, Republic of
  Connect »

Jun-Mo Yang, Professor

Samsung Medical Center
Seoul, Korea, Republic of
  Connect »

Kyu-Han Kim, Professor

Seoul National University Hospital
Seoul, Korea, Republic of
  Connect »

Dong-Ho Nam, Professor

Ajou University Hospital
Suwon, Korea, Republic of
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.